News & Events about Verastem Inc.
StockNews.com initiated coverage on shares of Verastem (NASDAQ:VSTM Get Rating) in a report published on Wednesday. The brokerage issued a hold rating on the biopharmaceutical companys stock. A number of other research analysts have also recently weighed in on the stock. HC Wainwright reiterated a ...
Ticker Report
2 months ago
Royal Bank of Canada reaffirmed their outperform rating on shares of Verastem (NASDAQ:VSTM Get Rating) in a research report released on Wednesday morning, Benzinga reports. Royal Bank of Canada currently has a $3.00 price objective on the biopharmaceutical companys stock. Several ...
Ticker Report
6 months ago
StockNews.com started coverage on shares of Verastem (NASDAQ:VSTM Get Rating) in a research note published on Monday morning. The brokerage issued a hold rating on the biopharmaceutical companys stock. A number of other equities research analysts have also recently weighed in on the ...
StockNews.com started coverage on shares of Verastem (NASDAQ:VSTM Get Rating) in a research note published on Monday morning. The brokerage issued a hold rating on the biopharmaceutical companys stock. A number of other equities research analysts have also recently weighed in on the stock. HC ...
Ticker Report
9 months ago
Principal Financial Group Inc. lowered its stake in shares of Verastem, Inc. (NASDAQ:VSTM Get Rating) by 27.0% during the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 200,197 shares of the biopharmaceutical companys stock after selling 74,...